Stratus™ Medical announces issuance of third United States patent for the Nimbus® RF Multitined Expandable Electrode used in the treatment of pain
News provided by
Share this article
Share this article
MAGNOLIA, Texas, Feb. 23, 2021 /PRNewswire/ Stratus™ Medical, a company focused on advancing radiofrequency ablation (RFA) treatment for chronic pain, announced today that the United States Patent and Trademark Office has granted a third U.S. patent related to its Nimbus® RF Multitined Expandable Electrode. U.S. Patent No. 10,925,664, titled METHODS FOR RADIO FREQUENCY NEUROTOMY, issued on February 23, 2021.
Stratus Medical s newest U.S. patent contains 29 method claims, including claims directed to nerve ablation for pain relief. These claims provide broad protection for Stratus Medical s Nimbus technology. Stratus Medical now holds three U.S. patents and 18 patents outside the U.S. on this technology, with several additional patent applications pending.